Most Active Articles 2009-11-24T12:33:10.129-05:00 Business Exchange Business_Exchange@businessweek.com urn:com:businessweek:bx:topic:most-active:johnson--johnson Carlton St Bernard cstbernard454 urn:com:businessweek:bx:article:13580349519666135866-29f9a2084e8e6ed001ba7f898419b5b8 2009-11-04T14:53:44.050-05:00

Two weeks after Johnson & Johnson (NYSE:JNJ) reported mixed earnings, which tugged stocks downward, the world's biggest healthcare company is looking to cut costs. Those cuts include 7,000 to 8,000 layoffs, mostly overseas.

Two weeks after Johnson & Johnson (NYSE:JNJ) reported mixed earnings, which tugged stocks downward, the world's biggest healthcare company is looking to cut costs. Those cuts include 7,000 to 8,000 layoffs, mostly overseas. http://www.thedeal.com/corporatedealmaker/2009/11/jj_chief_calls_job_cuts_diffic.php Brennen Wysong bwysong598 44 44 0 0 urn:com:businessweek:bx:article:16936065082414819425-43e6c5aa2eb77870ae3ec956ddf4f738 2009-10-12T13:24:47.410-04:00

Johnson & Johnson (NYSE:JNJ), the world's biggest healthcare company that's been squeezed by generic competition, reports third-quarter earnings Tuesday morning. Alex Gorsky, worldwide chairman of medical devices and diagnostics; Dominic Caruso, vice president of finance and CFO; and Louise Mehrotra, VP of investor relations, will speak about the report via Webcast at 8:30 a.m. ET.

Johnson & Johnson (NYSE:JNJ), the world's biggest healthcare company that's been squeezed by generic competition, reports third-quarter earnings Tuesday morning. Alex Gorsky, worldwide chairman of medical devices and diagnostics; Dominic Caruso, vice president of finance and CFO; and Louise Mehrotra, VP of investor relations, will speak about the report via Webcast at 8:30 a.m. ET. http://www.thedeal.com/corporatedealmaker/2009/10/johnson_johnson_earnings_previ.php Brennen Wysong bwysong598 26 26 0 0 urn:com:businessweek:bx:article:13069619104652839970-7da03af6e379f187839dd22384220eef 2009-04-13T05:52:00.000-04:00

How many employees may be fired in the Johnson & Johnson layoffs? As per the reports, there are going to be 900 job cuts by Johnson & Johnson.

How many employees may be fired in the Johnson & Johnson layoffs? As per the reports, there are going to be 900 job cuts by Johnson & Johnson. http://invest-n-trade.blogspot.com/2009/04/johnson-johnson-j-layoffs-job-cut-fires.html 147 146 1 0 urn:com:businessweek:bx:article:15814000339050616165-381c0405455badb091085824f64d8954 2009-02-24T22:31:00.000-05:00

was one, with talk it could choose to build on its dental subsidiary Astra Tech. The other was Johnson & Johnson, which has been linked with Nobel Biocare in the past. The speculation was triggered by a disclosure from UBS showing it had lowered its

was one, with talk it could choose to build on its dental subsidiary Astra Tech. The other was Johnson & Johnson, which has been linked with Nobel Biocare in the past. The speculation was triggered by a disclosure from UBS showing it had lowered its http://c.moreover.com/click/here.pl?r1837803463&f=9791 56 56 0 0 urn:com:businessweek:bx:article:15011496167699723833-f5ec7d44d20cb24107bf8239ecbd7692 2009-03-27T21:10:00.000-04:00

Johnson & Johnson is preparing a push to extract concessions from Schering-Plough in exchange for allowing Merck’s planned $46bn takeover of Schering to move forward without a messier fight, dealmakers

Johnson & Johnson is preparing a push to extract concessions from Schering-Plough in exchange for allowing Merck’s planned $46bn takeover of Schering to move forward without a messier fight, dealmakers http://c.moreover.com/click/here.pl?r1891847001&f=9791 49 49 0 0 urn:com:businessweek:bx:article:17945683755221172134-e55a3c7f4fd6b7f54865ba14e11c4707 2009-04-14T08:11:00.000-04:00

NEW YORK (Reuters) - Johnson & Johnson (JNJ.N The diversified health-care company, whose shares rose more than 3 percent in premarket trading, said it earned $3.51 billion, or $1.26 per share, in

NEW YORK (Reuters) - Johnson & Johnson (JNJ.N The diversified health-care company, whose shares rose more than 3 percent in premarket trading, said it earned $3.51 billion, or $1.26 per share, in http://c.moreover.com/click/here.pl?r1921226067&f=9791 34 34 0 0 urn:com:businessweek:bx:article:10949865948932486291-c9c84bdb5ec683a549781a5764b7fe12 2009-09-29T09:52:39.577-04:00

Amid rising concern about the threat of influenza pandemics, three big drug makers announced deals Monday that give them rights to new flu vaccines, placing bets on one of the pharmaceutical industry's brightest, but riskiest, segments. The deals reflect the growing conviction among pharmaceutical executives that vaccines against a variety of maladies, long an industry stepchild, will become an increasingly important source of growth to replace aging blockbusters that are poised to lose patent protection.

Amid rising concern about the threat of influenza pandemics, three big drug makers announced deals Monday that give them rights to new flu vaccines, placing bets on one of the pharmaceutical industry's brightest, but riskiest, segments. The deals reflect the growing conviction among pharmaceutical executives that vaccines against a variety of maladies, long an industry stepchild, will become an increasingly important source of growth to replace aging blockbusters that are poised to lose patent protection. http://online.wsj.com/article/SB125417905531847679.html?mod=WSJ_hps_LEFTWhatsNews Michael Arndt marndt561 2 2 0 0 urn:com:businessweek:bx:article:3388701241290628527-b5cca817f59bbc154d1ecb195c825824 2008-12-19T02:24:00.000-05:00

in any stock. So I want to suggest a stock that should let you sleep well at night: Johnson & Johnson (NYSE: JNJ).  It's probably a company you've known since childhood, since your mom shook its baby powder onto your tush. Since then, I suspect, you

in any stock. So I want to suggest a stock that should let you sleep well at night: Johnson & Johnson (NYSE: JNJ).  It's probably a company you've known since childhood, since your mom shook its baby powder onto your tush. Since then, I suspect, you http://c.moreover.com/click/here.pl?r1739695191&f=9791 57 57 0 0 urn:com:businessweek:bx:article:10906085536734853655-aa98fd95a5a452512edb86004000d166 2009-09-28T16:39:59.988-04:00

The pharmaceutical industry has seen a ton of deals over the past two years -- with $230 billion in M&A activity from the top 10 pharma companies alone since the beginning of 2007. But with plenty of players since on the board, there's likely to be...

The pharmaceutical industry has seen a ton of deals over the past two years -- with $230 billion in M&A activity from the top 10 pharma companies alone since the beginning of 2007. But with plenty of players since on the board, there's likely to be... http://www.thedeal.com/dealscape/2009/09/pharma.php Brennen Wysong bwysong598 1 1 0 0 urn:com:businessweek:bx:article:7302055230533414703-5d635ffca5d341013878bf9fe61ebdad 2009-09-29T15:31:16.559-04:00

We're tracking a subsector that's been hot with dealmaking -- oncology.

We're tracking a subsector that's been hot with dealmaking -- oncology. http://www.thedeal.com/corporatedealmaker/2009/09/keep_an_eye_on_oncology_deals.php Brennen Wysong bwysong598 0 0 0 0 urn:com:businessweek:bx:article:9067203919978902267-13f371f4c34b3bdca8a7d2136073ac71 2009-01-19T14:30:00.000-05:00

I'm AWFUL with people, I tend to ask them if they can read or speak english a lot and I'm a short little fatty so I'm not sure I could work a

I'm AWFUL with people, I tend to ask them if they can read or speak english a lot and I'm a short little fatty so I'm not sure I could work a http://spaceghetto.net/sandbox/index.php?/archives/26109-Every-Rectal-Thermometer-made-by-Johnson-Johnson-is-personally-tested..html 45 45 0 0 urn:com:businessweek:bx:article:14804792921525485803-3b7dd686b4170fad6867bd83d837cb97 2009-03-24T15:30:00.000-04:00

Johnson & Johnson China has held a press conference in Beijing, saying that tests by the company's quality department test show that Johnson

Johnson & Johnson China has held a press conference in Beijing, saying that tests by the company's quality department test show that Johnson http://www.chinamediablog.com/2009/03/25/johnson-johnson-china-no-recall-for-baby-products/ 25 25 0 0 urn:com:businessweek:bx:article:16176994300326117776-a0899b87ecd1e34350cb4317e5ae8f20 2009-04-23T11:02:14.490-04:00

Johnson and Johnson, one of the largest drug makers in the world, is in discussions with Indian drug companies and academic institutions for tie-ups in drug discovery research and opening a late stage drug development centre in Mumbai which will act as one of the key drug research centres for J&J worldwide.

Johnson and Johnson, one of the largest drug makers in the world, is in discussions with Indian drug companies and academic institutions for tie-ups in drug discovery research and opening a late stage drug development centre in Mumbai which will act as one of the key drug research centres for J&J worldwide. http://www.business-standard.com/india/news/jj-plans-advanced-drug-research-centre-in-mumbai/356009/ Michael Arndt marndt561 17 17 0 0 urn:com:businessweek:bx:article:4885047109044939300-8f7b96a5fbc7e6993e094432cbf4d06b 2008-11-09T19:54:55.962-05:00

CEO was about to leave or that the company could be taken over, with U.S. healthcare firm Johnson & Johnson (JNJ.N: Quote, Profile, Research, Stock Buzz) (J&J) named as one candidate. J&J declined to comment. The Nobel Biocare spokesman said Scala had to

CEO was about to leave or that the company could be taken over, with U.S. healthcare firm Johnson & Johnson (JNJ.N: Quote, Profile, Research, Stock Buzz) (J&J) named as one candidate. J&J declined to comment. The Nobel Biocare spokesman said Scala had to http://c.moreover.com/click/here.pl?r1677066564&f=9791 43 43 0 0 urn:com:businessweek:bx:article:4157885054465725327-e3ec422ab0e6f2c771e1d4c0abe1f4fd 2009-01-29T00:06:00.000-05:00

tumult, and uncertainty, you have to have moorings. Companies like P&G (PG, Fortune 500), GE (GE, Fortune 500), J&J (JNJ, Fortune 500), and IBM (IBM, Fortune 500) had an incredible fabric of values, of underlying ideals or principles that explained why

tumult, and uncertainty, you have to have moorings. Companies like P&G (PG, Fortune 500), GE (GE, Fortune 500), J&J (JNJ, Fortune 500), and IBM (IBM, Fortune 500) had an incredible fabric of values, of underlying ideals or principles that explained why http://c.moreover.com/click/here.pl?r1794792079&f=9791 31 31 0 0 urn:com:businessweek:bx:article:4250020079612246121-21d31a034cbb0ad42d644a8d49b61351 2009-05-22T08:59:28.197-04:00

Following similar deals by Switzerland's Novartis AG and Japan's biggest drug company, Takeda Pharmaceutical Co. Ltd., Johnson & Johnson (NYSE: JNJ) is acquiring Cougar Biotechnology Inc. (NASDAQ: CGRB), a development stage biopharmaceutical company with a specific focus on oncology for about $970 million in cash.

Following similar deals by Switzerland's Novartis AG and Japan's biggest drug company, Takeda Pharmaceutical Co. Ltd., Johnson & Johnson (NYSE: JNJ) is acquiring Cougar Biotechnology Inc. (NASDAQ: CGRB), a development stage biopharmaceutical company with a specific focus on oncology for about $970 million in cash. http://www.thedeal.com/corporatedealmaker/2009/05/jj_buys_cougar_biotechnology_f.php Tom Groppe tgroppe167 6 6 0 0 urn:com:businessweek:bx:article:2808814337784286660-e9e61d287810e9d796f6b17451ffd47a 2008-12-20T14:20:53.715-05:00

For companies passionate about growth and innovation, the unprecedented market events of the last two months seem to portend nothing but dark clouds. As financial titans fail Wall Street trembles, Main Street freezes, consumers panic, and everyone...

For companies passionate about growth and innovation, the unprecedented market events of the last two months seem to portend nothing but dark clouds. As financial titans fail Wall Street trembles, Main Street freezes, consumers panic, and everyone... http://www.businessweek.com/managing/content/dec2008/ca20081219_792901.htm?chan=careers_managing+index+page_top+stories Michael Arndt marndt561 16 16 0 0 urn:com:businessweek:bx:article:8476324759100733366-ef5dac54eaffe71dd3527b1249b8e921 2009-03-30T13:30:35.453-04:00

Video series MommyCast gains momentum. NEW YORK Gretchen Vogelzang and Paige Heninger are much like other suburban mothers, with seven children between them and busy schedules. The difference is they also have a high-powered Hollywood agent, ad campaigns with some of the world's top brands and distribution through Google's vast network.

Video series MommyCast gains momentum. NEW YORK Gretchen Vogelzang and Paige Heninger are much like other suburban mothers, with seven children between them and busy schedules. The difference is they also have a high-powered Hollywood agent, ad campaigns with some of the world's top brands and distribution through Google's vast network. http://www.adweek.com/aw/content_display/news/digital/e3icda4693bce31a5adaaa7b9d254568682?pn=1 Lauren Young lyoung404 9 8 0 1 urn:com:businessweek:bx:article:17776126047642373364-ca560c4f519e5c506f274c8263fdbdad 2009-08-09T14:56:47.636-04:00

Manikay Partners' portfolio reveals that the firm has been favoring healthcare, while dumping financials. Over the first quarter of 2009, Manikay purchased approximately $70million in healthcare stocks, while selling over $40 million in financial companies.

Manikay Partners' portfolio reveals that the firm has been favoring healthcare, while dumping financials. Over the first quarter of 2009, Manikay purchased approximately $70million in healthcare stocks, while selling over $40 million in financial companies. http://www.hedgetracker.com/article/Shane-Finemores-Manikay-Partners-Buying-Healthcare-Dumping-Financials Todd Walker rwienke085 0 0 0 0 urn:com:businessweek:bx:article:10001410591330321569-bd7b420a47fd316e6fa7c71286eef7ac 2009-03-11T14:32:16.717-04:00

Congress resumed its long-running patent reform debate March 10 with the usual intractable foes lining up for and against the primary sticking point in legislation introduced March 3: damages. High-tech companies want the damages formula in patent infringement lawsuits gutted; traditional manufacturing and pharmaceutical firms like it just the way it is.

Congress resumed its long-running patent reform debate March 10 with the usual intractable foes lining up for and against the primary sticking point in legislation introduced March 3: damages. High-tech companies want the damages formula in patent infringement lawsuits gutted; traditional manufacturing and pharmaceutical firms like it just the way it is. http://www.eweek.com/c/a/IT-Management/Patent-Reform-Debate-Opens-in-Congress/ Michael Arndt marndt561 8 8 0 0 urn:com:businessweek:bx:article:4843291851267413270-e7fd11e3864a186e568c1ad1d119591b 2009-04-20T18:55:51.703-04:00

For most of our adult lives, my wife and I have behaved in the way responsible cogs of capitalism.

For most of our adult lives, my wife and I have behaved in the way responsible cogs of capitalism. http://www.theatlantic.com/doc/200905/goldberg-economy Lauren Young lyoung404 4 4 0 0 urn:com:businessweek:bx:article:1309464833532545535-1177e025b3aa5ff3b5baabef4e326c82 2009-04-02T19:34:00.000-04:00

Where can I purchase J & J Hard Gloss-Glo coat floor wax?

Where can I purchase J & J Hard Gloss-Glo coat floor wax? http://www.thriftyfun.com/tf55792150.tip.html 8 8 0 0 urn:com:businessweek:bx:article:632473180146804132-8fe2ca3001cea8ceed94fdebcc9dff9f 2009-07-10T15:22:35.264-04:00

The Food and Drug Administration's position on acetaminophen, the active ingredient in Tylenol, is giving parent company Johnson & Johnson a branding headache, according to researcher YouGov.

The Food and Drug Administration's position on acetaminophen, the active ingredient in Tylenol, is giving parent company Johnson & Johnson a branding headache, according to researcher YouGov. http://www.drewkerrpress.com/2009/07/i-position-brandindexs-tylenol-research.html Drew Kerr dkerr475 0 0 0 0 urn:com:businessweek:bx:article:11088838430072158343-382e26e40bea5e94e3bbadc18291f861 2009-06-30T12:20:20.943-04:00

(Reuters) — A U.S. federal jury returned a $1.67 billion verdict against Abbott Laboratories in a patent suit brought by Johnson & Johnson related to arthritis treatments, the drug companies said on Monday. An Abbott spokesman said the company would appeal the verdict delivered in Marshall, Texas. The case involves Humira, Abbott's newer blockbuster drug that blocks tumor necrosis factor, or TNF, and which competes with Johnson & Johnson's older blockbuster medication Remicade.

(Reuters) — A U.S. federal jury returned a $1.67 billion verdict against Abbott Laboratories in a patent suit brought by Johnson & Johnson related to arthritis treatments, the drug companies said on Monday. An Abbott spokesman said the company would appeal the verdict delivered in Marshall, Texas. The case involves Humira, Abbott's newer blockbuster drug that blocks tumor necrosis factor, or TNF, and which competes with Johnson & Johnson's older blockbuster medication Remicade. http://www.chicagobusiness.com/cgi-bin/news.pl?id=34583&seenIt=1 Michael Arndt marndt561 1 1 0 0 urn:com:businessweek:bx:article:11886197001134989459-2e0576abb187197e412c1bddec814214 2009-03-16T01:00:00.000-04:00

The complicated reverse merger arrangement between Merck and Schering-Plough includes some impressive legal maneuvering.

The complicated reverse merger arrangement between Merck and Schering-Plough includes some impressive legal maneuvering. http://www.thetansheet.com/fdcreports/story/viewStory.do?targetAN=05170110003 11 11 0 0